| Robert J. Mulroy '91 |
"Yale SOM provided me with the perfect foundation for a career in the management of life sciences. Multi-sector challenges, opportunities, and conflicts abound in the lifecycle of a pharmaceutical company — from the earliest stages where technologies are born within our universities, to the latest stages where government regulation and purchasing drive the market. My Yale SOM education provided me with the analytical and organizational tools needed to succeed and the confidence to navigate a multi-sector, shifting landscape."
Robert Mulroy serves as the president and chief executive officer and a member of the board of directors of Merrimack Pharmaceuticals, Inc. Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts dedicated to the discovery and development of new medicines for the treatment of cancer. Since joining Merrimack, Mr. Mulroy has guided the financial, strategic direction, and operating growth of the company.
Mr. Mulroy worked previously as a management consultant supporting the strategic decisions of regional and global clients in the pharmaceutical and healthcare industries. He has also worked as an advisor to governments in the field of international development and formation of biotechnology clusters. Mr. Mulroy currently serves on the boards of the M.I.T. Center for Biomedical Innovation and Passim, a nonprofit music education and performance center serving greater Boston. He holds an AB from Stanford University and a masters degree in public and private management from the Yale School of Management.
Global Network for Advanced Management
Yale SOM Portal Yale University Sitemap Contact Privacy Policy
RSS 
Facebook 
TwitterThe Yale SOM website mba.yale.edu is produced by the Yale SOM Office of Communications.
Please send us your comments, questions, and feedback.
Copyright (c) 2000-2013 Yale School of Management. All rights reserved.